Small molecule compounds targeting miRNAs for cancer therapy

Area of Science:

• Molecular Oncology
• Non-coding RNA Biology

Background:

• Cancer involves genetic alterations in both coding and non-coding genes.
• MicroRNAs (miRNAs) are non-coding RNAs crucial to cancer hallmarks, often acting as oncomiRs.
• Current miRNA-inhibiting strategies face challenges with delivery agents and pharmacokinetics.

Purpose of the Study:

• To introduce small molecule inhibitors of specific miRNAs (SMIRs) as a novel therapeutic strategy.
• To describe high-throughput screening methods for identifying SMIRs.
• To highlight the unmet need for effective miRNA-based cancer therapeutics.

Main Methods:

• In vitro and in silico high-throughput screening techniques for SMIR identification.
• Validation of identified SMIRs.

Main Results:

• Development of a novel therapeutic strategy using SMIRs.
• Identification and validation of several SMIRs.

Conclusions:

• SMIRs represent a promising, novel therapeutic avenue for cancer treatment.
• Advanced screening methods facilitate the discovery of effective SMIRs.
• Addressing delivery and pharmacokinetic challenges is key for miRNA-based therapeutics.